CL vs FHTX · P/E 34, rev $10.69B vs rev $19.3M
Colgate-Palmolive Company (CL) versus Foghorn Therapeutics Inc (FHTX) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. FHTX currently screens at market cap $237.8M.
Not investment advice. Open the CL and FHTX stock pages for the full models.
Not investment advice.